Gene · 7704
Papers3,197
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,197
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation. | PLoS Genet | 2022 | 36288392 | PubTator, text mining | PubMed |
| The genetics of occupational asthma development among workers exposed to diisocyanates: A systematic literature review with meta-analysis. | Front Genet | 2022 | 36276967 | PubTator, text mining | PubMed |
| Target tumor microenvironment by innate T cells. | Front Immunol | 2022 | 36275727 | PubTator, text mining | PubMed |
| Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates. | Front Immunol | 2022 | 36275702 | PubTator, text mining | PubMed |
| Waves of layered immunity over innate lymphoid cells. | Front Immunol | 2022 | 36268032 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient. | Front Immunol | 2022 | 36248860 | PubTator, text mining | PubMed |
| Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device. | Front Cardiovasc Med | 2022 | 36247468 | PubTator, text mining | PubMed |
| Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family. | Front Endocrinol (Lausanne) | 2022 | 36246927 | PubTator, text mining | PubMed |
| In vitro propagation of XXY human Klinefelter spermatogonial stem cells: A step towards new fertility opportunities. | Front Endocrinol (Lausanne) | 2022 | 36246909 | PubTator, text mining | PubMed |
| Quercetin supplementation alters adipose tissue and hepatic transcriptomes and ameliorates adiposity, dyslipidemia, and glucose intolerance in adult male rats. | Front Nutr | 2022 | 36245490 | PubTator, text mining | PubMed |
| Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2022 | 36243813 | PubTator, text mining | PubMed |
| RUNX1/CEBPA Mutation in Acute Myeloid Leukemia Promotes Hypermethylation and Indicates for Demethylation Therapy. | Int J Mol Sci | 2022 | 36232714 | PubTator, text mining | PubMed |
| STAT3 and Its Pathways' Dysregulation-Underestimated Role in Urological Tumors. | Cells | 2022 | 36230984 | PubTator, text mining | PubMed |
| Locus-Specific Enrichment Analysis of 5-Hydroxymethylcytosine Reveals Novel Genes Associated with Breast Carcinogenesis. | Cells | 2022 | 36230901 | PubTator, text mining | PubMed |
| Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2022 | 36230636 | PubTator, text mining | PubMed |
| Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen. | Endocr Relat Cancer | 2022 | 36219867 | PubTator, text mining | PubMed |
Case Report: Successful therapy with all-trans retinoic acid combined with chemotherapy followed by hematopoietic stem cell transplantation for acute promyelocytic leukemia carrying the BCOR-RARA fusion gene. | Front Oncol | 2022 | 36212492 | PubTator, text mining | PubMed |
| Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. | Front Oncol | 2022 | 36212403 | PubTator, text mining | PubMed |
| Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. | Cell Rep Med | 2022 | 36208629 | PubTator, text mining | PubMed |
| Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. | Front Pharmacol | 2022 | 36204232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7704/papers?page=27